The weight loss journey isnt just about losing weightits about keeping the weight off , reducing long-term disease risk, and improving quality of life
Accordingly, postbiotics should be interpreted as adjunctive nutritional strategies rather than pharmacological alternatives to GLP-1 receptor agonists, with the most plausible utility during consolidation and maintenance phases aimed at improving metabolic context and supporting long-term weight-loss sustainability ( Figure 1 Importantly, accumulating preclinical evidence indicates that certain postbiotic preparations can attenuate weight gain, reduce adiposity, and activate thermogenic pathways, including brown adipose tissue signaling, particularly in high-fat dietfed rodent models

Start with 0.25 mg once weekly for the first 4 weeks Increase to 0.5 mg once weekly starting from week 5 Administer in the abdomen , thigh , or upper arm Missed dose: Administer within 5 days, otherwise skip and resume on next scheduled day Rotate injection sites weekly within the same region OZEMPIC 0.5mg (Japanese) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes and to reduce the risk of cardiovascular events in those with existing heart disease
Semaglutide belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists and is known for its dual benefits: it helps control blood glucose levels in adults with type 2 diabetes and supports weight loss in people with or without diabetes (off-label) when used in combination with diet and increased physical activity
Tirzepatide has extensive Phase 3 and post-marketing safety data through Mounjaro and Zepbound